semaglutide vs peptides for weight loss and Tirzepatide: Key Differences Explained Understanding GLP-1 and Its Role

Key secondary endpoints related to physical fitness were changes from randomization to the end of treatment (weeks 052) in: (1) physical functional performance (time to ascend and descend an 11-step stairway twice)

In crude analyses, GLP-1 receptor agonist use was associated with an increased incidence of suicidality compared with DPP-4 inhibitors (crude incidence rates 3.9 v 1.8 per 1000 person years, respectively

Updating our priors after the one-year anniversary of our original GLP-1 Primer

Hers will stop offering the compounded semaglutide weight-loss pills, after discussions with regulators and broader industry consultations

These results highlight significant heterogeneity in weight trajectories following sustained exposure to a GLP-1RA therapy and identifies factors associated with increased weight loss, likely reflecting a combination of biological, behavioral, and social factors

Gastric bypass patients sometimes face weight regain years after surgery